Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors
Clinical trial NCT00352131 · COMPLETED
Trial details
- NCT number
- NCT00352131
- Sponsor
- ImmunoGen, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2009-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.